Creo Medical Group PLC (CREO) — Cash Flow-to-Debt Ratio
Creo Medical Group PLC (CREO) has a Cash Flow-to-Debt Ratio of -3.76x as of December 2025, meaning its operating cash flow of GBX-34.20 Million could theoretically repay -4% of its total liabilities (GBX9.10 Million) in one year. Explore Creo Medical Group PLC long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Creo Medical Group PLC Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Creo Medical Group PLC across 14 annual periods. Also explore Creo Medical Group PLC assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Creo Medical Group PLC (2014–2025)
Year-by-year debt coverage analysis for Creo Medical Group PLC. For market capitalisation and broader financial context, see market value of Creo Medical Group PLC.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.04x | GBX-18.60 Million | GBX9.10 Million | ▼ -108.1% |
| 2024 | -0.98x | GBX-22.20 Million | GBX22.60 Million | ▲ +23.6% |
| 2023 | -1.29x | GBX-21.60 Million | GBX16.80 Million | ▼ -33.4% |
| 2022 | -0.96x | GBX-24.99 Million | GBX25.93 Million | ▼ -1.2% |
| 2021 | -0.95x | GBX-25.98 Million | GBX27.29 Million | ▼ -75.5% |
| 2020 | -0.54x | GBX-16.09 Million | GBX29.66 Million | ▲ +73.7% |
| 2019 | -2.06x | GBX-11.54 Million | GBX5.60 Million | ▲ +70.5% |
| 2018 | -6.98x | GBX-14.20 Million | GBX2.03 Million | ▼ -128.6% |
| 2018 | -3.05x | GBX-7.00 Million | GBX2.29 Million | ▲ +35.0% |
| 2017 | -4.70x | GBX-6.91 Million | GBX1.47 Million | ▼ -126.0% |
| 2016 | -2.08x | GBX-1.64 Million | GBX788.81K | ▲ +64.6% |
| 2016 | -5.87x | GBX-3.13 Million | GBX532.79K | ▲ +23.7% |
| 2015 | -7.69x | GBX-2.27 Million | GBX295.98K | ▼ -41.3% |
| 2014 | -5.44x | GBX-1.36 Million | GBX250.20K | — |